Research Paper Volume 14, Issue 17 pp 7038—7051

The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer


Figure 6. The link between the ALDH6A1 expression and immunoinhibitors of GC patients. (A) The picture has conveyed the relationship between ALDH6A1 expression and immunoinhibitors. (B) The scatter plots have depicted the top four immunoinhibitors which possessed a negative link with ALDH6A1 expression.